We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
MGM Resorts International
MGM
$7.16B
| $349K | 0.1% |
+7,290
| New | +$303K |
2026 Q2
0 quarters
|
|
152
Intuitive Surgical
ISRG
$153B
| $348K | 0.1% |
875
-102
| -10% | -$44.6K |
2025 Q4
2 quarters
|
|
153
PUT
Kodiak Sciences
KOD
$5.74B
| $345K | 0.1% |
372
-253
| -40% | -$9.8K |
2026 Q1
1 quarter
|
|
154
CALL
BioAge Labs
BIOA
$229M
| $343K | 0.1% |
+510
| New | +$9.21K |
2026 Q2
0 quarters
|
|
|
HELP
155
Helus Pharma Inc. Common Stock
HELP
$781M
| $337K | 0.1% |
+50,979
| New | +$255K |
2026 Q2
0 quarters
|
|
156
A2Z Smart Technologies
AZ
$261M
| $331K | 0.1% |
+56,935
| New | +$389K |
2026 Q2
0 quarters
|
|
157
Integer Holdings
ITGR
$4.31B
| $330K | 0.1% |
+3,528
| New | +$313K |
2026 Q2
0 quarters
|
|
158
Equillium
EQ
$78.6M
| $326K | 0.1% |
102,010
-8,107
| -7% | -$19.4K |
2025 Q3
3 quarters
|
|
159
Royalty Pharma
RPRX
$26.8B
| $325K | 0.1% |
5,797
+619
| +12% | +$32.2K |
2025 Q4
2 quarters
|
|
160
Nextpower Inc. Common Stock
NXT
$12.1B
| $321K | 0.1% |
+2,874
| New | +$355K |
2026 Q2
0 quarters
|
|
161
Lionsgate Studios
LION
$3.16B
| $308K | 0.09% |
+20,146
| New | +$260K |
2026 Q2
0 quarters
|
|
162
Ezcorp Inc
EZPW
$2.01B
| $308K | 0.09% |
+8,913
| New | +$281K |
2026 Q2
0 quarters
|
|
163
ProShares VIX Short-Term Futures ETF
VIXY
$231M
| $307K | 0.09% |
+14,443
| New | +$379K |
2026 Q2
0 quarters
|
|
164
CG Oncology
CGON
$5.31B
| $302K | 0.09% |
4,250
-7,389
| -63% | -$483K |
2025 Q4
2 quarters
|
|
165
Xeris Biopharma Holdings
XERS
$2B
| $282K | 0.08% |
35,661
| – | – |
2025 Q3
3 quarters
|
|
166
Jazz Pharmaceuticals
JAZZ
$13.5B
| $280K | 0.08% |
1,164
-14,741
| -93% | -$3.23M |
2025 Q1
5 quarters
|
|
167
OceanaGold Corp
OGC
$5.93B
| $280K | 0.08% |
+11,204
| New | +$335K |
2026 Q2
0 quarters
|
|
168
Wynn Resorts
WYNN
$7.82B
| $278K | 0.08% |
+2,867
| New | +$296K |
2026 Q2
0 quarters
|
|
169
SLB Ltd
SLB
$72.8B
| $278K | 0.08% |
6,000
+4,000
| +200% | +$214K |
2025 Q4
2 quarters
|
|
170
Legend Biotech
LEGN
$3.63B
| $277K | 0.08% |
+9,579
| New | +$258K |
2026 Q2
0 quarters
|
|
171
Tenet Healthcare
THC
$21.4B
| $275K | 0.08% |
+1,471
| New | +$270K |
2026 Q2
0 quarters
|
|
172
CALL
Corvus Pharmaceuticals
CRVS
$812M
| $274K | 0.08% |
340
+70
| +26% | +$971 |
2026 Q1
1 quarter
|
|
173
Flutter Entertainment
FLUT
$13.4B
| $274K | 0.08% |
2,682
-9,101
| -77% | -$938K |
2026 Q1
1 quarter
|
|
174
Pharvaris
PHVS
$2.09B
| $273K | 0.08% |
7,904
| – | – |
2026 Q1
1 quarter
|
|
175
Comfort Systems
FIX
$51.5B
| $270K | 0.08% |
+136
| New | +$247K |
2026 Q2
0 quarters
|
|
Similar funds
JWM
PI
TFA
SIM
OWM
SS
BIA
TODC
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.